1. Universidade Federal da Bahia

Página de Busca


Filtros correntes:



Retornar valores
Adicionar filtros:

Utilizar filtros para refinar o resultado de busca.

 | 
Resultado 1-10 de 23.
Conjunto de itens:
Data do documentoTítuloAutor(es)Tipo
2001Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloningProbst, Peter; Stromberg, Erika J.; Ghalib, Hashim W.; Mozel, Michelle; Badaró, Roberto José da Silva; Reed, Steven G.; Webb, John R.Artigo de Periódico
Set-2000Molecular and immunological characterization of mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in mycobacterium bovis BCGDillon, Davin C.; Alderson, Mark R.; Day, Craig H.; Bement, Teresa; Campos Neto, Antonio; Skeiky, Yasir A. W.; Vedvick, Thomas S.; Badaró, Roberto José da Silva; Reed, Steven G.; Houghton, RaymondArtigo de Periódico
Ago-2003Use of rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trialPedral Sampaio, Diana Brasil; Martins Netto, Eduardo; Brites, Carlos; Bandeira, Antonio Carlos de Albuquerque; Guerra, Conceição; Barberin, Maria Goreth; Badaró, Roberto José da SilvaArtigo de Periódico
15-Mar-2000Identification of differentially expressed genes in human prostate cancer using subtraction and microarrayXu, Jiangchun; Stolk, John A.; Silva, Sandra J.; Houghton, Raymond L.; Vedvick, Thomas S.; Badaró, Roberto José da Silva; Reed, Steven G.Artigo de Periódico
2007HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinantsBrennan, Catherine A.; Brites, Carlos; Bodelle, Pierre; Golden, Alan; Hackett Júnior, John; Badaró, Roberto José da Silva; Holzmayer, Vera; Swanson, Priscila; Vallari, Ana; Yamaguchi, Julie; Devari, Sushil; Pedroso, Celia; Ramos, AndréArtigo de Periódico
2003Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalizationCorrêa, João Carlos; Badaró, Roberto José da Silva; Bumroongkit, Chaiwat; Mera, Jorge Raúl; Dolmann, Alberto Lorenzo; Martínez, Luis Guillermo Juárez; Mayrinck, Lusane Romero; Tamez, Ricardo; Yang, Joanna Y.Artigo de Periódico
Ago-2001Evaluation of viral resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1-infected patients before and after 6 months of single or double antiretroviral therapyAlves, Carlos Roberto Brites; Bahia, Fabianna Márcia Maranhão; Gilbert, Mark; Pedroso, Célia; Badaró, Roberto José da SilvaArtigo de Periódico
2000Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas’ diseaseHoughton, Raymond L.; Benson, Darin R.; Reynolds, Lisa; McNeill, Patricia; Sleath, Paul; Lodes, Michael J.; Skeiky, Yasir A. W.; Badaró, Roberto José da Silva; Krettli, Antoniana U.; Reed, Steven G.Artigo de Periódico
2003An adherence trilogy is essential for long-term HAART successGarcia, Rosa; Schooley, Robert T.; Badaró, Roberto José da SilvaArtigo de Periódico
Fev-2004Gatifloxacin in the treatment of community-acquired pneumonias. A comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumoniaMendonça, J. S.; Yamaguti, A.; Corrêa, J. C.; Badaró, Roberto José da SilvaArtigo de Periódico

Busca facetada